What is the purpose of this trial?
The purpose of this study is to evaluate whether oral finerenone (study drug), in addition to standard daily therapy, is effective and safe in treating patients with type 2 diabetes mellitus and diabetic kidney disease, when compared to a placebo.
Ages: 18 years and older
Bayer Healthcare Pharmaceuticals, Inc.
Start Date: 03/04/2016
End Date: 04/30/2019
Last Updated: 06/22/2018
Study HIC#: 1511016771